aap Implantate received FDA 510(k) clearance to market LOQTEQ® VA foot plates 2.5. Launch will commence in 2020.
LOQTEQ VA treats fractures and malpositions in the forefoot and midfoot. The variable angle polyaxial implants allow insertion of screws at different angles. Revision plates complete the set.
The company announced earlier this week that it will discontinue parts of its standard trauma portfolio by the end of 2019, focusing instead on LOQTEQ plates, silver coating technology and resorbable magnesium implants.
aap Implantate received FDA 510(k) clearance to market LOQTEQ® VA foot plates 2.5. Launch will commence in 2020.
LOQTEQ VA treats fractures and malpositions in the forefoot and midfoot. The variable angle polyaxial implants allow insertion of screws at different angles. Revision plates complete the set.
The company announced earlier...
aap Implantate received FDA 510(k) clearance to market LOQTEQ® VA foot plates 2.5. Launch will commence in 2020.
LOQTEQ VA treats fractures and malpositions in the forefoot and midfoot. The variable angle polyaxial implants allow insertion of screws at different angles. Revision plates complete the set.
The company announced earlier this week that it will discontinue parts of its standard trauma portfolio by the end of 2019, focusing instead on LOQTEQ plates, silver coating technology and resorbable magnesium implants.
Copy to clipboard 
